Dr. LI Zhigang serves as the consultant of Surgery (Specialty in Thoracic Surgery) at Jiahui Health. Dr. Li obtained his M.D. and Ph.D. degree from the Second Military Medical Dr. LI Zhigang serves as the consultant of Surgery (Specialty in Thoracic Surgery) at Jiahui Health. Dr. Li obtained his M.D. and Ph.D. degree from the Second Military Medical University (SMMU) of China, and then completed the surgery and cardiothoracic surgery residency training in Cardiovascular & Thoracic Surgery Department at the Changhai Hospital affiliated to SMMU, and was subsequently hired to work there as an attending surgeon and assistant professor of SMMU. After completing the American Association for Thoracic Surgery (AATS) Graham Fellowship training in the United States in 2012, Dr. Li joined the Shanghai Chest Hospital and has served as the Director of Thoracic Surgery and Director of Esophageal Surgery. Dr. Li has extensive clinical experience of the diagnosis and treatment in all fields of general thoracic surgery, focusing on the precise diagnosis and stratified treatment of lung cancer. He has excellent experience in the treatment of rare and complex diseases in the fields of trachea, mediastinum, and chest wall. He has built and is leading the worldwide large robot-assisted minimally invasive surgery center for esophageal cancer, and led multiple international cutting-edge clinical research projects, and is good at providing patients with the effective treatment results through multidisciplinary collaboration.

Dr. Li’s specialty includes the following but not limited to:

Achalasia; Adenocarcinomas of the esophagogastric junction; Barrett’s esophagus; Bullous Disease; Chest wall tumor; Chylothorax; Congenital lung malformation (e.g. pulmonary sequestration); COPD (limited to lung transplant evaluation); Cystic fibrosis (limited to lung transplant evaluation); Diaphragmatic hernia; Dysphagia; Emphysema; Endobronchial Tumor; Esophageal Cancer; Esophageal diverticula; Esophageal foreign bodies; esophageal perforation; Esophageal stricture (include chemical material corrosion damage); Gastroesophageal reflux disease (GERD); Hiatal hernia; Hyperhidrosis; Interstitial lung disease (lung biopsy and evaluation of lung transplant); Lung cancer; Lung mass (diagnose and treatment); Lung Nodule (especially GGO diagnosis and treatment); Mediastinal tumor; Mesothelioma; Myasthenia gravis; Neurogenic tumors of the mediastinum; Pancoast tumor; Pectus excavatum; Pleural effusion; Pleural mass; Pneumothorax; Pulmonary fibrosis (limited to lung transplant evaluation); Pulmonary Metastasis; Thoracic cancer; Thoracic outlet syndrome; Thymus tumor; Tracheal stenosis (Dr. Li is skilled in intubation and tracheal stenosis after incision); Tracheoesophageal fistula; Tracheal tumor; Tracheo-gastric fistula.

Dr. HU Dingzhong is the specially-invited expert of thoracic surgery at Jiahui International Health. He serves as chief physician of thoracic surgery in the Shanghai Chest Hospital. Dr. Hu has been devoted to thoracic surgery clinical work for nearly 30 years, with an annual operation volume of more than 2,000 cases. He has accumulated rich clinical experience in thoracic surgery. Dr. Hu specializes in the diagnosis, differential diagnosis, and surgical treatment of chest benign and malignant diseases such as lung, esophagus, mediastinum, chest wall l, and trachea. He is especially skilled at complex surgical operations of thoracic surgery, including various high complex tracheal tumors, tracheal stenosis, and complex tumor surgical operations on the top of the chest, as as well as vena cava replacement in the treatment of thymic tumors. In the past 10 years, Dr. Hu has extensively carried out minimally invasive thoracic surgeries. He is skilled in all kinds of central complicated lung and mediastinal surgery under thoracoscope. He has performed the leading amount of thoracic robotic surgery cases in China. He also focuses on research for the surgical treatment of emphysema and lung transplantation for various end-stage lung diseases.

Dr. JIANG Gening serves as the consultant of Thoracic Surgery at Jiahui Health. He is also the chief clinical expert, discipline leader and director of the research department of thoracic surgery at Shanghai Lung Hospital Affiliated to Tongji University, and deputy director of Surgery Department of Medical College of Tongji University. Furthermore, Dr. Jiang is a member of the Standing Committee of the Chinese society of thoracic and cardiac surgery and head of the lung cancer group, a former chairman of the thoracic surgery branch of the Shanghai Medical Association (the first and second sessions). He is also an academician of the American College of surgery (FACS), an academician of the Royal College of Surgery (FRCS), an AATS member the American College of Thoracic Surgery, and a deputy chief editor of the Chinese Journal of thoracic and cardiovascular surgery.

Dr. Jiang is specialized in clinical and translational research on surgical treatment of lung cancer, tracheal surgery, lung transplantation, mediastinal / chest wall tumors and difficult infectious diseases of the lung.

Dr. Jiang’s team is committed to the clinical and translational research of various diseases in thoracic surgery, has carried out long-term in-depth work in the clinical research field of surgical treatment of lung cancer, minimally invasive surgery, tracheal surgery, lung transplantation, mediastinal / chest wall tumors, pleural mesothelioma and difficult infectious diseases of the lung. Dr. Jiang’s team promoted the progress of many clinical technologies and the transformation of clinical concepts. Based on the difficult clinical problems of thoracic surgery, the team focuses on building new technologies / ideas / methods to produce leading original breakthroughs.

Dr. Jiang is an expert with outstanding contributions to the Ministry of health and enjoys the special allowance of the State Council. Dr. Jiang is an advanced worker in the national health and family planning system. He received awards like the Shanghai medical development outstanding contribution award, Shanghai leading talent, Shanghai May Day labor medal, Shanghai top ten doctors, and the "outstanding achievements" of the Fifth People's famous doctors.

Dr. Gening Jiang presided over 16 scientific research projects, , with a total of 583 papers were published,. Dr. Gening Jiang cumulated 345.763 IF points, including 5 IF > 10 points (JAMA oncology, advanced materials, etc.), 28 papers in the three core journals of international thoracic surgery (jtcvs, ATS, ejcts), and 80 Chinese series papers. He edited and translated 18 monographs such as lung surgery and lung transplantation. He served as the deputy editor in chief and Editorial Committee of more than 10 thoracic surgery works, including six planning textbooks for colleges and universities. Formulate and publish 7 domestic and international expert consensus. He has won 15 awards at all levels, including the second prize of national scientific and Technological Progress Award (second), the first prize and second prize of Shanghai Scientific and technological progress award. He also won the second prize of Chinese medical science and Technology Award (3 times), the second prize of scientific and technological progress award of the Ministry of education and the second prize of Shanghai Medical Science and Technology Award (2 times).

Dr. LUO Qingquan serves as the multi-site practicing physician at Jiahui Health. He is the Chief Physician of Thoracic Surgery, Doctoral Supervisor, Executive Deputy Director of Oncology Department of Shanghai Chest Hospital, Fellow of the American Academy of Surgeons (FACS), Vice President of the First Committee of the Chinese Medical Robotics Association, Chinese Medical Doctor Association Founding Chairman of the Thoracic Surgery Professional Committee of the Medical Robotic Physician Branch, Deputy Chairman of the Thoracic Surgery Professional Committee of the Department of Simulation Medicine of the Wu Jieping Medical Foundation, Standing Committee Member of the First Endoscopic and Robotic Surgery Branch of the Chinese Anti-Cancer Association, Thoracoscopy of the Thoracic Surgery Branch of the Chinese Medical Doctor Association Standing member of the professional committee, member of the Chinese Society of Clinical Oncology (CSCO), member of the Standing Committee of the Minimally Invasive Surgery Expert Committee of the Thoracic Surgeons Branch of the Chinese Medical Doctor Association, expert with special allowance from the State Council. Dr. Luo has worked in thoracic surgery for nearly 20 years, accumulated rich experience in the clinical aspect of thoracic surgery such as lung cancer, mediastinal tumors, esophagus, trachea, etc. He is skilled at surgical treatment of thoracic diseases, including lung, esophagus, trachea, mediastinum, etc. He has performed more than 5,000 operations, and has led more than 3,000 cases, including many severe cases.

Dr. ZHAO Xiaogang is currently an Associate Chief Physician of Thoracic Surgery at Shanghai Pulmonary Hospital. He is also an Associate Professor, and a supervisor of master students at Shanghai Tongji University. Dr. Zhao graduated from Shanghai Jiaotong University School of Medicine with a doctorate degree in thoracic surgery. In 2015, he went to the United States as a visiting scholar for half a year, visited the Barnes hospital of UNMC University and Washington University in St. Louis. Dr. Zhao has worked in thoracic surgery field for more than 20 years, specializing in minimally invasive thoracoscopic surgery, single-port thoracoscopic minimally invasive treatment of small pulmonary nodules (GGN, GGO, ground glass nodules), tracheal surgery, bronchoplasty sleeve surgery, pulmonary bulla surgery. Dr. Zhao is skilled in the diagnosis of benign and malignant small lung nodules and ground glass nodules and minimally invasive single-port thoracoscopic surgery. He operated more than 1000 lung operations per year.

Dr. ZHU Yuming is the consultant of Shanghai Jiahui International Hospital and currently the director of the Thoracic Surgery Department at Shanghai Pulmonary Hospital. He has worked within the thoracic surgery field at Shanghai Pulmonary Hospital since 1988, focused on the standardized treatment of lung cancer and the surgical treatment of esophageal and mediastinal diseases as well as refractory tuberculosis. Since 1996, he has worked on minimally invasive surgeries, including thoracoscopes and mediastinoscopes, and has accumulated decades of experience in minimally invasive surgery.

Over the last ten years, Dr. Zhu has been engaged in clinical research on the surgical treatment of end-stage lung disease. Dr. Zhu’s project, The Application of Video-assisted Thoracoscopy in Pulmonary Surgery, won First Price at the Shanghai Science and Technology Progress Awards, Second Price at the China Medical Science and Technology Awards, the Shanghai Medical Science and Technology Promotion Awards, as well as at the Ministry of Education Science and Technology Progress Awards.

Dr. Zhu has a special allowance from the State Council and is a visiting professor at the Charité – Universitätsmedizin Berlin in Germany.

Specialties
1. The treatment of benign lung diseases, bronchiectasis, mediastinal tumors, and early-stage lung cancer using minimally invasive surgical approaches, including video-assisted thoracoscopic surgery.
2. Standardized treatment of lung cancer.
3. Lung volume reduction surgery, lung transplantation, and other treatment methods for end-stage lung disease.

Dr. AN Chaolun, deputy chief physician, is now working in the Thoracic Surgery Department of Jiahua Health. He has more than 15 years of clinical experience in thoracic surgery, and can provide diagnosis and treatment of common chest diseases such as lung cancer, esophageal cancer, mediastinal tumor, and chest trauma.

Dr. An’s treatment specialties include but are not limited to:
· Pulmonary diseases: pulmonary nodules, bullosa, spontaneous pneumothorax, bronchiectasis, bronchial cyst, bronchial tumor, tracheal stenosis, etc.
· Esophageal diseases: esophageal cancer, cardia cancer, gastroesophageal reflux disease, hiatal hernia, etc.
· Mediastinal diseases: mediastinitis, mediastinal emphysema, mediastinal cyst, thymoma, teratoma, neurofibroma, etc.;
· Chest trauma: rib fracture, hemothorax, pneumothorax, lung contusion and laceration, etc.
· Pleural diseases: empyema, nontraumatic hemothorax, spontaneous pneumothorax
· Others: costal chondritis, hidrosis, etc

Prior to joining Jiahui, Dr. An has been working in public grade A class 3 hospital hospital, accumulating rich clinical experience, and completed advanced study in cardiothoracic Surgery, Shanghai Changhai Hospital in 2012, and Esophageal Surgery, Shanghai Chest Hospital in 2022. Dr. An is the third-level training object of Nantong City's "226 High-level Talent Training Project". He also has won the third prize of Nantong City for medical new technology introduction. Dr. An participated in the compilation of "Modern cardiothoracic Surgery disease Basis and Clinical" and published a number of SCI articles already.

Dr. XIE Dong, Associate Chief Physician, Associate Professor, Doctoral Supervisor, went to Mayo Clinic (Mayo Center) in the United States from 2013 to 2014 to study at the Thoracic Surgery and Cancer Center. His annual operation volume is more than 1,000 cases. Dr. Dong Xie is a Shanghai Pujiang Talent, Shanghai Medical Garden "Rising Star" outstanding young medical talent, member of IASLC (International Association for the Study of Lung Cancer), member of EACTS (European Society of Thoracic and Cardiovascular Surgeons), member of ESTS (European Society of Thoracic and Cardiovascular Surgeons), STS (Member of American Society of Thoracic Surgeons). His 2015 "Minimally Invasive Surgical Treatment of Early Stage Lung Cancer with Ground Glass Shadow" won the first-prize clinical achievement in Shanghai Pulmonary Hospital.

Dr. Dong Xie specializes in the minimally invasive treatment of pulmonary ground glass nodules, ground glass shadows, GGN, GGO, pulmonary nodules and early lung cancer, and single-port minimally invasive treatment of pulmonary nodules (including solid and subsolid nodules) surgical treatment. He also specializes in the comprehensive treatment of lung cancer, thymic tumors (thymoma, thymic cyst, thymic cancer), and mediastinal tumors.

Dr. YE Bo is currently a supervisor of master students at Shanghai Jiaotong University and Associate Chief Physician of Thoracic Surgery at Shanghai Chest Hospital. Dr. Bo Ye obtained his Doctor of Medicine degree from Peking Union Medical College, where he received excellent clinical and scientific research training, and worked in thoracic surgery for 18 years ever since then. He has an outstanding clinical ability, having presided over and participated in over 10,000 thoracic surgeries. His total number of operations exceeds 1,500 units per year. Dr. Bo Ye is proficient in thoracoscopic surgery for lung cancer, esophageal cancer, mediastinal tumors, bullae, pneumothorax, chest wall sinus, pectus excavatum, and other surgical operations. Dr. Bo Ye had zero deaths of patients who received surgery and the rate of complications is extremely low.

From 2014 to 2015, Dr. Bo Ye went to MD Anderson Cancer Hospital and Duke University, Washington University Hospital and Toronto General Hospital to study and hone his medical skills for one year. At present, he focuses on the surgical treatment of early lung cancer and esophageal cancer, pneumothorax, and mediastinal tumors. He is well-versed in thoracoscopic surgery. He has meticulous and exquisite surgery skills, amiable attitude towards patients, as well as rich experiences in a variety of difficult cases.

Dr. Bo Ye specializes in the diagnosis and treatment of lung cancer, esophageal cancer, mediastinal tumors, bullae, pneumothorax, chest wall sinus, pectus excavatum and other diseases. He is good at thoracoscopic surgery, and his surgery skills are meticulous and exquisite.

HE Wenxin, chief physician of Thoracic Surgery Department of Shanghai Pulmonary Hospital, associate professor of Tongji University, doctoral supervisor, postdoctoral co-supervisor, is now a multi - practitioner of thoracic surgery department of Jiahui Health.
Dr. He has more than 20 years of clinical experience in thoracic surgery, and he specializes in the treatment of early-middle and operable lung malignancies, benign lung diseases and various mediastinal diseases with single-aperture thoracoscopy. He is good at the early diagnosis of lung cancer, the diagnosis and treatment of ground glass nodule and other lung nodule; specializes in lung transplantation for end-stage lung disease. He is also good at the surgical treatment of trachea tumors, stenosis and other airway diseases. From June 2011 to June 2012, he visited Massachusetts General Hospital to learn thoracic tumor surgery techniques and tracheal surgery techniques.

Dr. He has been engaged in the clinical and basic research of lung transplantation for a long time, and has presided over 6 funds including the National Natural Science Foundation Project, Youth Project of National Natural Science Foundation and the Shanghai Science and Technology Commission. His project of surgical treatment of end-stage lung disease won the second prize of 2012 China Medical Science and Technology Award. As the first author or corresponding author, he has published more than 30 academic papers in The Journal of Thoracic and Cardiovascular Surgery, European Journal of Cardio-Thoracic Surgery, Annals of Surgical Oncology and other journals. He has participated in the compilation of many monographs such as Pulmonary Surgery, the second and third editions of Diagnosis and Decision of Difficult Diseases in Thoracic Surgery, and Thoracic Surgery.

Dr. He is a member of lung transplantation group, Organ transplantation branch, Chinese Medical Association; Editorial board member of Chinese Journal of organ transplantation； a member of Organ Transplantation Committee of China Rehabilitation Medical Association；a young member of organ transplantation branch，Shanghai Medical Association.

Dr. Xanthia YANG, thoracic surgeon at Jiahui Medical.
Dr. YANG graduated from the Naval Medical University with a master's degree in surgery (Cardiothoracic Surgery). After completing the standardized resident training in the First Affiliated Hospital of Naval Medical University, she successively worked in the Thoracic Surgery Department of Shanghai First People's Hospital (Jiading branch) and Cardiovascular surgery of Shanghai Fourth People's Hospital. Participated in the outpatient and emergency diagnosis and treatment, surgical treatment and perioperative management of common diseases of thoracic surgery.

She has participated various kinds of surgeries, such as thoracoscopic lobectomy/segmentectomy, non-anatomical sub lobar resection, Ivor Lewis surgery, McKeown surgery, thoracoscopic resection of benign esophageal tumors, thoracoscopic resection of mediastinal tumors, and surgical stabilization of multiple rib fractures.

Dr.YANG’s treatment specialties include but are not limited to:
Surgical treatment and perioperative management of common diseases in thoracic surgery, such as lung cancer, esophageal cancer, mediastinal tumor, rib fracture, and spontaneous pneumothorax.

SUN Xiwen, Chief physician of the Radiology Department of Shanghai Pulmonary Hospital, Ph.D supervisor and Master Supervisor of Tongji University;

Specialties:
Dr.SUN research direction is lung difficult diseases and artificial intelligence AI, and he is good at the diagnosis and differential diagnosis of lung "ground glass nodules", especially at the image reading of lung diseases.

Experience:
Dr.SUN has published more than 100 articles in both Chinese and English, won two Shanghai Science and Technology Achievement Awards, and trained more than 50 international students, doctors and masters.
Dr.SUN has won the National Science and Technology Progress Award and served as a review expert of Shanghai Science and Technology Progress Award.

Wang Haifeng, chief physician, is currently the administrative deputy director of the thoracic Surgery Department of Shanghai Pulmonary Hospital.

Specialties:

The annual operation volume is 1000+ sets, the diagnosis and treatment range include but not limited to lung cancer, mediastinal tumor, lung nodule, trachea tumor, pneumothorax, rib fracture and other common diseases of thoracic surgery, especially specializes in single-hole minimally invasive surgery treatment of early lung cancer and surgical treatment of chest wall tumor.

Experience:

After graduating from Shanghai Medical University with a master's degree, Dr. Wang worked in Shanghai Pulmonary Hospital and received his doctorate degree from Shanghai Second Military Medical University in 2010.

From March to September 2006, Dr.Wang went to the Thoracic Surgery Department of Melbourne Hospital in Australia for six months to learn the clinical diagnosis and treatment of lung cancer. From May 2013 to April 2014, he went to the United States for one year to study.

While in the United States, he studied trachea surgery, lung transplantation and minimally invasive thoracic surgery at Massachusetts General Hospital, Harvard University, Barnes-Jewish Hospital, University of Washington, and Cedars-Sinai Medical Center.

Academic position:

Vice Chairman of Youth Committee of China Medical Promotion Association

Young member of Thoracic Surgeons Branch, Chinese Medical Doctor Association

Member of STS, Member of Shanghai Anti-Cancer Association - Lung Cancer Committee

Member of the Special Committee of Translational Medicine, Shanghai Anticancer Association

Member of the special Committee of Thoracic Surgery, Shanghai Association of Integrated Chinese and Western Medicine reviewer of Chinese Journal of Experimental Surgery.

Deputy chief physician of Thoracic Surgery, Shanghai Pulmonary Hospital.

Specialties:
Thoracoscopic minimally invasive surgery for early lung cancer, differential diagnosis and treatment of small pulmonary nodules, comprehensive treatment of lung cancer and other chest tumors, diagnosis and treatment of mediastinal tumors, pneumothorax, pulmonary bulla and other common diseases in general thoracic surgery.

Research direction:
1. Minimally invasive thoracic surgery;
2. Differential diagnosis and surgical treatment of pulmonary nodules;
3. Neoadjuvant combined surgical treatment of lung cancer.